3004.90.92.55/Pantoprazole Sodium 40mg Delayed-Release Tablets/Canada

Pantoprazole Sodium 40mg Delayed-Release Tablets from Canada

These are oral delayed-release tablets containing 40mg of pantoprazole sodium, a proton pump inhibitor used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. They fall under HTS 3004.90.92.55 as unmixed medicaments put up in measured doses for retail sale, primarily affecting the digestive system via pantoprazole or its salts.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Verify pantoprazole content via certificate of analysis to confirm classification under 3004.90.92.55; mislabeling risks reclassification

• Ensure FDA registration and NDC labeling for retail packs; provide stability data for delayed-release formulations

• Avoid bulk shipments without measured doses, as they may shift to unmixed chemical headings like 2933

Pantoprazole Sodium 40mg Delayed-Release Tablets from Canada — Import Duty Rate | HTS 3004.90.92.55